Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma.
Yunxiu LuoXiaopeng HuangJiabin ZhanShuai ZhangPublished in: International journal of general medicine (2021)
CD5L can facilitate individualized, targeted therapy for HCC patients.